June 06, 2011 12:20pm EDT
Download as PDF
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE Amex: OPK) today announced the completion of the
redemption of its Series A Preferred Stock. Of the 722,700 shares of our
Series Preferred Stock outstanding as of March 31, 2011, 602,758 shares
were redeemed for cash of $2.50 per share plus $0.35 of accrued, unpaid
dividends, and 119,942 shares were converted, prior to redemption, into
shares of our Common Stock, on a one-to-one basis.
About OPKO Health, Inc.
We are a multi-national pharmaceutical and diagnostics company that
seeks to establish industry-leading positions in large and rapidly
growing medical markets by leveraging our discovery, development and
commercialization expertise and our novel and proprietary technologies.
Our current focus is on conditions with major unmet medical needs
including neurological disorders, infectious diseases, oncology and
ophthalmologic diseases.
Source: OPKO Health, Inc.
Released June 6, 2011
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page